Vanda Pharmaceuticals Inc. (VNDA)

21.00
0.97 4.80
NASDAQ : Health Technology
Prev Close 20.03
Open 20.44
Day Low/High 20.27 / 21.41
52 Wk Low/High 13.88 / 33.44
Volume 677.72K
Avg Volume 862.10K
Exchange NASDAQ
Shares Outstanding 52.45M
Market Cap 1.07B
EPS 0.50
P/E Ratio 42.42
Div & Yield N.A. (N.A)
Short Interest Moves 14.3% Lower For VNDA

Short Interest Moves 14.3% Lower For VNDA

The most recent short interest data has been released by the NASDAQ for the 03/31/2016 settlement date, which shows a 1,020,996 share decrease in total short interest for Vanda Pharmaceuticals Inc , to 6,127,734, a decrease of 14.28% since 03/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Vanda Pharmaceuticals (VNDA) Flagged As Strong On High Volume

Vanda Pharmaceuticals (VNDA) Flagged As Strong On High Volume

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a strong on high relative volume candidate

Interesting VNDA Put And Call Options For September 16th

Interesting VNDA Put And Call Options For September 16th

Investors in Vanda Pharmaceuticals Inc saw new options become available this week, for the September 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks

2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks

I'm only making one big prediction this year: The five-year party which saw biotech stocks outperform the broader markets comes to an end in 2016.

3 Biotech Stocks Under $10 Making Big Moves

3 Biotech Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Stocks Insiders Love for 2016

5 Stocks Insiders Love for 2016

Insiders at these companies have been scooping up shares of their own stock lately.

Vanda Pharmaceuticals Enters Oversold Territory (VNDA)

Vanda Pharmaceuticals Enters Oversold Territory (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BOCH, HHC, HMIN, PLCM, PRIM, QLYS, RUBI, SFST, SPTN Downgrades: CCO, CDI, DCO, DIOD, FSTR, IBM, ICON, LIOX, OMCL, QUAD, SAVE, STWD, TIME, VET, VNDA Initiations: HUBS, OMAM, OPHT, OSGB, VBTX Read on to get TheStreet Quant Ratings' detailed report:

First Week of June 2016 Options Trading For Vanda Pharmaceuticals (VNDA)

First Week of June 2016 Options Trading For Vanda Pharmaceuticals (VNDA)

Investors in Vanda Pharmaceuticals Inc saw new options become available this week, for the June 2016 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Vanda Pharmaceuticals (VNDA): Today's Weak On High Volume Stock

Vanda Pharmaceuticals (VNDA): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a weak on high relative volume candidate

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Vanda Pharmaceuticals (VNDA) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a strong on high relative volume candidate

Vanda Pharmaceuticals (VNDA) Weak On High Volume

Vanda Pharmaceuticals (VNDA) Weak On High Volume

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a weak on high relative volume candidate

Intra-Cellular Surges on Optimistic Outlook for Schizophrenia Drug

Intra-Cellular Surges on Optimistic Outlook for Schizophrenia Drug

Schizophrenia patients treated with an experimental drug from Intra-Cellular Therapies reported fewer antipsychotic symptoms compared to a placebo in a large, phase III study, the company said Wednesday.

Vanda Pharmaceuticals (VNDA) Flagged As Strong On High Volume

Vanda Pharmaceuticals (VNDA) Flagged As Strong On High Volume

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a strong on high relative volume candidate

First Week Of VNDA October 16th Options Trading

First Week Of VNDA October 16th Options Trading

Investors in Vanda Pharmaceuticals Inc saw new options become available this week, for the October 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new October 16th contracts and identified one put and one call contract of particular interest.

Notable Two Hundred Day Moving Average Cross - VNDA

Notable Two Hundred Day Moving Average Cross - VNDA

In trading on Thursday, shares of Vanda Pharmaceuticals Inc crossed below their 200 day moving average of $11.56, changing hands as low as $11.49 per share. Vanda Pharmaceuticals Inc shares are currently trading down about 2.4% on the day.

Vanda Pharmaceuticals (VNDA) Is Strong On High Volume Today

Vanda Pharmaceuticals (VNDA) Is Strong On High Volume Today

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a strong on high relative volume candidate

Oversold Conditions For Vanda Pharmaceuticals (VNDA)

Oversold Conditions For Vanda Pharmaceuticals (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Vanda Pharmaceuticals (VNDA) Is Strong On High Volume Today

Vanda Pharmaceuticals (VNDA) Is Strong On High Volume Today

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a strong on high relative volume candidate

Interesting VNDA Put And Call Options For August 21st

Interesting VNDA Put And Call Options For August 21st

Investors in Vanda Pharmaceuticals Inc saw new options become available this week, for the August 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new August 21st contracts and identified one put and one call contract of particular interest.

Interesting VNDA Put And Call Options For July 17th

Interesting VNDA Put And Call Options For July 17th

Investors in Vanda Pharmaceuticals Inc saw new options become available this week, for the July 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new July 17th contracts and identified one put and one call contract of particular interest.

4 Biotech Stocks Under $10 to Trade for Breakouts

4 Biotech Stocks Under $10 to Trade for Breakouts

These under-$10 biotech stocks are within range of triggering breakout trades.

Strong On High Volume: Vanda Pharmaceuticals (VNDA)

Strong On High Volume: Vanda Pharmaceuticals (VNDA)

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a strong on high relative volume candidate

First Week of VNDA May 15th Options Trading

First Week of VNDA May 15th Options Trading

Investors in Vanda Pharmaceuticals Inc saw new options become available this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VNDA options chain for the new May 15th contracts and identified one put and one call contract of particular interest.

Vanda Pharmaceuticals is Now Oversold (VNDA)

Vanda Pharmaceuticals is Now Oversold (VNDA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Vanda Pharmaceuticals (VNDA) Strong On High Relative Volume Today

Vanda Pharmaceuticals (VNDA) Strong On High Relative Volume Today

Trade-Ideas LLC identified Vanda Pharmaceuticals (VNDA) as a strong on high relative volume candidate

6 Health Care Stocks John Paulson Is Betting On for 2015

6 Health Care Stocks John Paulson Is Betting On for 2015

Here's a closer look at five health care stocks Paulson & Co. bought in the most recently reported quarter.

Valeant Deal a Good Thing for Billionaire Investors

Valeant Deal a Good Thing for Billionaire Investors

Valeant, Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) and Enzymotec Ltd. (NASDAQ:ENZY) are approaching market close with noteworthy gains this Monday. Voltari Corp. (NASDAQ:VLTC), Cobalt International ...

Vanda Pharmaceuticals (VNDA) Shares Cross Above 200 DMA

Vanda Pharmaceuticals (VNDA) Shares Cross Above 200 DMA

In trading on Friday, shares of Vanda Pharmaceuticals Inc crossed above their 200 day moving average of $12.50, changing hands as high as $12.63 per share. Vanda Pharmaceuticals Inc shares are currently trading down about 0.2% on the day.

First Week of VNDA September 18th Options Trading

First Week of VNDA September 18th Options Trading

Investors in Vanda Pharmaceuticals Inc saw new options begin trading this week, for the September 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

TheStreet Quant Rating: C+ (Hold)